Evidence for active regulation of pro-osteogenic signaling in advanced aortic valve disease. - Wikidata - wikimedia - TriplyDB

Evidence for active regulation of pro-osteogenic signaling in advanced aortic valve disease.

Evidence for active regulation of pro-osteogenic signaling in advanced aortic valve disease.

http://www.wikidata.org/entity/Q34378569

about

Cellular mechanisms of aortic valve calcification Fibrocalcific aortic valve disease: opportunity to understand disease mechanisms using mouse models Pathophysiology of Aortic Valve Stenosis: Is It Both Fibrocalcific and Sex Specific?Calcific aortic valve stenosis: methods, models, and mechanisms In vitro 3D model and miRNA drug delivery to target calcific aortic valve disease.Osteoprotegerin inhibits aortic valve calcification and preserves valve function in hypercholesterolemic mice Defining the role of fluid shear stress in the expression of early signaling markers for calcific aortic valve disease.Animal models of calcific aortic valve disease Endothelial-derived oxidative stress drives myofibroblastic activation and calcification of the aortic valve Calcific aortic valve disease: not simply a degenerative process: A review and agenda for research from the National Heart and Lung and Blood Institute Aortic Stenosis Working Group. Executive summary: Calcific aortic valve disease-2011 update.Pioglitazone attenuates valvular calcification induced by hypercholesterolemia.Fibrotic Aortic Valve Stenosis in Hypercholesterolemic/Hypertensive Mice.Improvement of aortic valve stenosis by ApoA-I mimetic therapy is associated with decreased aortic root and valve remodelling in mice Transcriptional and phenotypic changes in aorta and aortic valve with aging and MnSOD deficiency in mice.Vascular function during prolonged progression and regression of atherosclerosis in mice.Serum phosphate is associated with aortic valve calcification in the Multi-ethnic Study of Atherosclerosis (MESA)Cardiac valve cells and their microenvironment--insights from in vitro studies.Shear-Sensitive Genes in Aortic Valve Endothelium.Pathophysiology of Aortic Stenosis and Mitral Regurgitation.Differential activation of valvulogenic, chondrogenic, and osteogenic pathways in mouse models of myxomatous and calcific aortic valve disease.Bone morphogenetic protein-4 and transforming growth factor-beta1 mechanisms in acute valvular response to supra-physiologic hemodynamic stresses.Impact of hypertension and renin-angiotensin system inhibitors in aortic stenosis.Hypoxia and Local Inflammation in Pulmonary Artery Structure and Function.Calcific Aortic Valve Disease: a Developmental Biology Perspective.Increased Calcific Aortic Valve Disease in response to a diabetogenic, procalcific diet in the LDLr-/-ApoB100/100 mouse model.Unanswered Questions Regarding Sex and BMP/TGF-β Signaling.Monocytes and Macrophages in Heart Valves: Uninvited Guests or Critical Performers?Scanning electron microscopy for blood micro-crystals in aortic stenosis patients The Genetic Regulation of Aortic Valve Development and Calcific Disease

P2860

Q24613042-6B31A5BB-61AE-45AE-8EFC-10E3C58330A1 Q26994661-B15CE8E1-620B-4A5C-9602-DCF905B67152 Q30234828-11AD336B-E21F-4368-A730-27296E9629C3 Q30503246-C57F8D72-5565-41E2-95D5-357CAA1391E2 Q33765102-FAF60B2B-C503-426A-AA80-30FCED2D1B65 Q34769687-17EB71F2-2D4C-4D7D-9549-612EF4146266 Q35078393-8D37E0E7-30CA-42F6-82D0-43112A69099C Q35147157-E4D1C6AC-21D2-4D60-96D4-65E192D6BF67 Q35601573-76A27103-D2DE-4776-814B-9D553E26A7AE Q35836894-B1215EE8-4159-4D64-A0A2-F9745CEB1CA1 Q36612212-C7F5E273-CA62-47B5-9077-225CA8647A3F Q36619540-7842FD99-738A-46DB-AF29-91E153C10AA8 Q37046783-8E560063-F150-44AF-BBED-BC335B985753 Q37342163-67ACAE90-9CC4-4AAB-9037-A249F9E91BCC Q37651668-86F43832-6F0F-441F-B0C7-1451EDDD25D5 Q37711157-B33BE845-8EEF-4FD9-B994-35F05E7CFBE9 Q38259727-3D642206-4C3A-461F-BF41-A0A4D1E05565 Q38664184-D1E34E1B-C77A-40AA-B115-9F7ABD05CDD1 Q39390979-12D5D0A9-5000-42DF-90BE-36E52519BBC1 Q42128207-0F877C9D-3EC5-430C-8AA1-6675CE8F4DDB Q42219498-677EE8D3-59BC-4F06-B0C3-C6A000708A30 Q44322817-6B284C4F-472C-4483-9167-E76391B40F80 Q46280825-1C77FB31-4ABD-405A-87AB-F8AE45909B43 Q50420240-B6447960-A61B-4810-8FFD-6F4DB3A1F8C4 Q52655804-B9BA6412-E329-430D-9884-C2E1D35EE204 Q55657934-C7D58C38-0A97-4FCB-9247-269835D934D2 Q57147723-036B6625-0304-4EBC-925B-B20C35F0AFD0 Q58715661-42A42698-4321-4016-96F7-5D1FF061464E Q59136506-74B22150-C6D4-4A39-9FF2-D15980080279

P2860

Evidence for active regulation of pro-osteogenic signaling in advanced aortic valve disease.

http://www.wikidata.org/entity/Q34378569

description

2010 nî lūn-bûn

@nan

2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Evidence for active regulation ...... advanced aortic valve disease.

@ast

Evidence for active regulation ...... advanced aortic valve disease.

@en

Evidence for active regulation ...... advanced aortic valve disease.

@nl

type

label

Evidence for active regulation ...... advanced aortic valve disease.

@ast

Evidence for active regulation ...... advanced aortic valve disease.

@en

Evidence for active regulation ...... advanced aortic valve disease.

@nl

prefLabel

Evidence for active regulation ...... advanced aortic valve disease.

@ast

Evidence for active regulation ...... advanced aortic valve disease.

@en

Evidence for active regulation ...... advanced aortic valve disease.

@nl

P1433

Q34378569-49CE41FB-3300-4F6E-9E90-5F47ABC19480

P1476

Q34378569-2BED5D09-665C-46AB-BC0B-759FD5C07977

P2093

Q34378569-05E60A6A-3CD8-4D23-97E9-12BF4565B0B3

Q34378569-1B947E60-31D2-47FC-8E63-98721B25CF7A

Q34378569-3B91AF66-A5F1-4918-A9C5-58AFFEAC789A

Q34378569-4372C2BC-113E-4E66-A152-C9FB77BAC05B

Q34378569-624B989E-E185-4E8E-89CC-B2EBF506734F

Q34378569-96CAA53B-F9A8-411D-B585-9C348E6553A2

Q34378569-F570E522-D85B-4C2F-91B0-93836C96158F

P2860

Q34378569-0946B2F6-0C35-4784-AA4D-D28A25BD4261

Q34378569-144F9B57-F9FE-4206-B8B1-5B81B1B155D8

Q34378569-1E5EB2F6-6D6A-4849-9169-DF77592AFAEA

Q34378569-1F7AB54E-197E-4230-ACC7-81142A6DD1D9

Q34378569-27DE004F-C80B-445F-8378-9154B23864C9

Q34378569-2FA32577-F44D-4CE0-ACB9-DB9685399372

Q34378569-319AA25B-55E1-4E09-ABBD-F97A46587521

Q34378569-384970B2-081F-4056-BA62-528100ED2396

Q34378569-4B68C9ED-035C-4F01-95EF-E4B8CF341E3F

Q34378569-6BC27EFD-2923-4E70-BD55-3B415A1639F5

P304

Q34378569-D5EAEFEB-C1A0-46BE-9B83-4CBDB3033C2D

P31

Q34378569-6C412C0B-F354-43B0-A599-87E875B19406

P356

Q34378569-3B8FC6E8-049F-456B-9FC7-DAD8ED628E53

P407

Q34378569-1112717F-3A56-45DD-A476-A0AB1A3D34C6

P433

Q34378569-CAE4E7E6-6835-41E7-92A4-D142E720A742

P478

Q34378569-9DA4339B-F92F-4281-9C94-6775E78B12D5

P577

Q34378569-662158D8-84C2-49F9-9AB6-A98361A68724

P5875

Q34378569-EBFC2FF4-43C1-45EB-8BC7-82365301E351

P698

Q34378569-518351EB-D371-4850-85CC-92EBF21C1CD4

P921

Q34378569-02E0E13F-1343-462A-A30E-FF5F7A048C29

P932

Q34378569-EEFB3EB2-CD2B-4AFA-A041-973B3A559027

P356

ATVBAHA.110.211029

P1433

Arteriosclerosis, Thrombosis, and Vascular Biology

P1476

Evidence for active regulation ...... advanced aortic valve disease.

@en

P2093

Donald D Heistad

http://www.w3.org/2001/XMLSchema#string

Jordan D Miller

http://www.w3.org/2001/XMLSchema#string

Kathy Zimmerman

http://www.w3.org/2001/XMLSchema#string

Kristine M Serrano

http://www.w3.org/2001/XMLSchema#string

Lauren E Castaneda

http://www.w3.org/2001/XMLSchema#string

Robert M Brooks

http://www.w3.org/2001/XMLSchema#string

Robert M Weiss

http://www.w3.org/2001/XMLSchema#string

P2860

Lamellar bone formation in an atherosclerotic plaque of the carotid artery, with a review of histogenesis--a case report.

Progressive coronary calcification despite intensive lipid-lowering treatment: a randomised controlled trial

Oxidative stress induces vascular calcification through modulation of the osteogenic transcription factor Runx2 by AKT signaling.

Fibroblast growth factor represses Smad-mediated myofibroblast activation in aortic valvular interstitial cells

Efficacy of simvastatin treatment of valvular interstitial cells varies with the extracellular environment.

Dysregulation of antioxidant mechanisms contributes to increased oxidative stress in calcific aortic valvular stenosis in humans.

Correlates of valvular ossification in patients with aortic valve stenosis.

Bone morphogenetic protein expression in human atherosclerotic lesions.

Atherosclerotic calcification: relation to developmental osteogenesis.

Lowering plasma cholesterol levels halts progression of aortic valve disease in mice.

P304

2482-2486

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1161/ATVBAHA.110.211029

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

30

http://www.w3.org/2001/XMLSchema#string

P577

2010-09-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

46413965

http://www.w3.org/2001/XMLSchema#string

P698

20864669

http://www.w3.org/2001/XMLSchema#string

P921

P932

2996870

http://www.w3.org/2001/XMLSchema#string